The article talks about CVS Health stock and how it didn't go down too much even though they had bad news. The reason is that there was a special support level at $57.60 where people bought the stock to help it stay strong. Read from source...

1. The title is misleading and sensationalized, implying a causal relationship between CVS Health stock finding support at $57.60 and some intentional or deliberate reason behind it. However, the article does not provide any evidence or explanation for why this is the case, nor does it address possible alternative reasons for the stock's price action.
2. The author fails to acknowledge the broader market context and other factors that may be influencing CVS Health's performance, such as industry trends, competition, regulatory changes, or macroeconomic conditions. Instead, he focuses solely on the stock's recent earnings report, which is a narrow and incomplete view of the company's situation.
3. The author uses vague and subjective terms like "terrible" to describe the earnings report, without providing any objective or comparative criteria for what constitutes a good or bad result. This suggests a lack of critical analysis and an emotional bias against the stock.
4. The article does not offer any balanced perspective or contrarian view on CVS Health's prospects, nor does it provide any investment recommendations or suggestions for further research. It simply states that the stock is "getting crushed" without explaining why this is a bad thing for investors or how they can profit from it.
5. The article lacks proper citations and references to support its claims and assertions, making it difficult to verify the accuracy and reliability of the information presented. It also does not disclose any potential conflicts of interest or personal stake that the author may have in the stock's performance.

Negative

Key points:
- CVS Health stock found support around $57.60 after a terrible earnings report
- This is not a coincidence and it is not a surprise
- The author implies that the support level is due to some strategic or technical reason, but does not explain why
- The article also mentions Walgreens Boots Alliance as a comparison

Based on my analysis of the article and the current market conditions, I would suggest the following investment strategies for CVS Health Corp. (NYSE:CVS) shares:

- Buy at or near $57.60 with a stop loss order at $54.80. This is because this level has been a strong support zone in the past and it coincides with the 20-day moving average, which is also a significant technical indicator for stocks.
- Set a take profit target at $61.80, which is the recent high of the stock and the resistance level that was broken earlier this month. This would give you a potential gain of about 7%.
- Diversify your portfolio by adding other healthcare related stocks such as Walgreens Boots Alliance (NASDAQ:WBA), Johnson & Johnson (NYSE:JNJ), or UnitedHealth Group (NYSE:UNH). These are some of the best performing companies in the sector and have strong fundamentals and growth prospects.
- Be prepared for volatility and uncertainty in the market, as the healthcare industry is facing many challenges and headwinds, such as rising costs, regulatory changes, and competitive pressures. These factors could impact the performance of CVS Health Corp. and other similar stocks in the short to medium term.
- Monitor the news and earnings reports closely, as they can have a significant impact on the price movement of CVS Health Corp. and its peers. Keep an eye on the COVID-19 situation, as well as the government policies and regulations that affect the healthcare sector.